Brief Information of the Cell Line and Protein
Cell Line ID: CL000017 , HeLa
Synonyms
HELA
Hela
He La
He-La
HeLa-CCL2
Henrietta Lacks cells
Helacyton gartleri
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0030
Protein ID: PT00894 , Androgen receptor
Gene Name AR
Organism Homo sapiens, Human
Protein Classification Transcription factor
Uniprot ID P10275
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000017  Protein ID: PT00894
 
Compound ID Compound Name Compound Formula
CP0188089
(5R)-3-(3,4-dichlorophenyl)-5-(4-hydroxyphenyl)-1,5-dimethyl-2-sulfanylideneimidazolidin-4-one
   Show/Hide
C17H14Cl2N2O2S
 1
1
Activity = 0.8 nM
   TI
   LI
   LO
   TS
CP0071838
4-[(4R)-4-(4-hydroxyphenyl)-3,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
   Show/Hide
C19H14F3N3O3
 1
1
Activity = 0.9 nM
   TI
   LI
   LO
   TS
CP0768499
(+/-)-4-[4-Hydroxymethyl-4-(4-hydroxy-phenyl)-3-methyl-2,5-dioxo-imidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C19H14F3N3O4
 1
1
Activity = 0.9 nM
   TI
   LI
   LO
   TS
CP0087810
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate
   Show/Hide
C22H32O3
 1
1
Activity = 1.5 nM
   TI
   LI
   LO
   TS
CP0217093
Enobosarm
   Show/Hide
C19H14F3N3O3
 1
1
Activity = 1.5 nM
   TI
   LI
   LO
   TS
CP0667051
(R)-4-[3,4-dimethyl-2,5-dioxo-4-(4-hydroxyphenyl)imidazolidin-1-yl]-2-methoxybenzonitrile
   Show/Hide
C19H17N3O4
 1
1
Activity = 1.5 nM
   TI
   LI
   LO
   TS
CP0674129
rac-2-chloro-4-[3,4-dimethyl-2,5-dioxo-4-(4-hydroxyphenyl)imidazolidin-1-yl]-3-methylbenzonitrile
   Show/Hide
C19H16ClN3O3
 1
1
Activity = 1.5 nM
   TI
   LI
   LO
   TS
CP0700989
rac-4-[3,4-Dimethyl-2,5-dioxo-4-(4-hydroxyphenyl)imidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
   Show/Hide
C19H14F3N3O3
 1
1
Activity = 1.6 nM
   TI
   LI
   LO
   TS
CP0667050
rac-4-[2,5-dioxo-4-(4-hydroxyphenyl)-4-methyl-3-(2-propenyl)imidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C21H16F3N3O3
 1
1
Activity = 2 nM
   TI
   LI
   LO
   TS
CP0780210
rac-1-(3,4-Dichlorophenyl)-3,4-dimethyl-4-(4-hydroxyphenyl)-2-thioxoimidazolidin-5-one
   Show/Hide
C17H14Cl2N2O2S
 1
1
Activity = 2 nM
   TI
   LI
   LO
   TS
CP0852267
rac-4-[3,4-dimethyl-2,5-dioxo-4-(4-hydroxyphenyl)imidazolidin-1-yl]-2-methoxybenzonitrile
   Show/Hide
C19H17N3O4
 1
1
Activity = 2.1 nM
   TI
   LI
   LO
   TS
CP0727743
rac-4-[2,5-dioxo-4-(4-hydroxyphenyl)-4-methyl-3-(2-propynyl)imidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C21H14F3N3O3
 1
1
Activity = 2.4 nM
   TI
   LI
   LO
   TS
CP0842955
rac-4-[3,4-dimethyl-2,5-dioxo-4-(4-hydroxyphenyl)imidazolidin-1-yl]-3-methyl-2-trifluoromethylbenzonitrile
   Show/Hide
C20H16F3N3O3
 1
1
Activity = 3 nM
   TI
   LI
   LO
   TS
CP0674128
rac-4-[3,4-dimethyl-4-(4-hydroxyphenyl)-5-oxo-2-thioxoimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C19H14F3N3O2S
 1
1
Activity = 4 nM
   TI
   LI
   LO
   TS
CP0917404
(+/-)-4-[4-(3-Chlorophenyl)-2,5-dioxo-4-hydroxymethyl-3-methylimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C19H13ClF3N3O3
 1
1
Activity = 5 nM
   TI
   LI
   LO
   TS
CP0957889
(+/-)-4-[2,5-Dioxo-3-ethyl-4-hydroxymethyl-4-phenylimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C20H16F3N3O3
 1
1
Activity = 7 nM
   TI
   LI
   LO
   TS
CP0044960
(1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one
   Show/Hide
C19H30O2
 1
1
Activity = 8 nM
   TI
   LI
   LO
   TS
CP0957888
(+/-)-4-[4-(4-Chlorophenyl)-2,5-dioxo-4-hydroxymethyl-3-methylimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C19H13ClF3N3O3
 1
1
Activity = 8 nM
   TI
   LI
   LO
   TS
CP0769734
rac-1-(3,4-dichlorophenyl)-3,4-dimethyl-4-(4-hydroxyphenyl)imidazolidine-2,5-dione
   Show/Hide
C17H14Cl2N2O3
 1
1
Activity = 10.9 nM
   TI
   LI
   LO
   TS
CP0957887
(+/-)-4-[4-(2,5-Dioxo-4-fluorophenyl)-4-hydroxymethyl-3-methylimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C19H13F4N3O3
 1
1
Activity = 11 nM
   TI
   LI
   LO
   TS
CP0782826
(+/-)-4-[2,5-Dioxo-4-(hydroxymethyl)-3-methyl-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
   Show/Hide
C19H14F3N3O3
 1
1
Activity = 12 nM
   TI
   LI
   LO
   TS
CP0946590
(S)-(-)-4-[2,5-Dioxo-4-(hydroxymethyl)-3-methyl-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
   Show/Hide
C19H14F3N3O3
 1
1
Activity = 13 nM
   TI
   LI
   LO
   TS
CP0946589
(+/-)-4-[2,5-Dioxo-4-hydroxymethyl-3-(1-methylethyl)-4-phenylimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C21H18F3N3O3
 1
1
Activity = 20 nM
   TI
   LI
   LO
   TS
CP0780882
(+/-)-4-[4-Hydroxymethyl-4-(4-methoxy-phenyl)-3-methyl-2,5-dioxo-imidazolidin-1-yl]-2-trifluoromethyl-benzonitrile
   Show/Hide
C20H16F3N3O4
 1
1
Activity = 30 nM
   TI
   LI
   LO
   TS
CP0077490
5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin
   Show/Hide
C12H10F3N3O4
 1
1
Activity = 37 nM
   TI
   LI
   LO
   TS
CP0818064
(+/-)-4-[4-(1H-Benzoimidazol-5-yl)-3,4-dimethyl-2,5-dioxo-imidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C20H14F3N5O2
 1
1
Activity = 40 nM
   TI
   LI
   LO
   TS
CP0881067
(+/-)-4-[2,5-Dioxo-4-hydroxymethyl-3-methyl-4-(3-methylphenyl)imidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C20H16F3N3O3
 1
1
Activity = 40 nM
   TI
   LI
   LO
   TS
CP0917595
(+/-)-4-[2,5-Dioxo-4-hydroxymethyl-4-phenyl-3-(2-propynyl)imidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C21H14F3N3O3
 1
1
Activity = 40 nM
   TI
   LI
   LO
   TS
CP0883503
(+/-)-4-[4-(2-Chlorophenyl)-2,5-dioxo-4-hydroxymethyl-3-methylimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C19H13ClF3N3O3
 1
1
Activity = 60 nM
   TI
   LI
   LO
   TS
CP0905266
(+/-)-1-(3,4-Dichlorophenyl)-4-hydroxymethyl-3-methyl-4-phenylimidazolidine-2,5-dione
   Show/Hide
C17H14Cl2N2O3
 1
1
Activity = 60 nM
   TI
   LI
   LO
   TS
CP0911592
(+/-)-4-(4-Hydroxymethyl-3-methyl-2,5-dioxo-4-phenyl-imidazolidin-1-yl)-2-methoxy-benzonitrile
   Show/Hide
C19H17N3O4
 1
1
Activity = 60 nM
   TI
   LI
   LO
   TS
CP0953485
(+/-)-4-[4-(3-Cyanophenyl)-2,5-dioxo-4-hydroxymethyl-3-methylimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C20H13F3N4O3
 1
1
Activity = 60 nM
   TI
   LI
   LO
   TS
CP0711588
(+/-)-4-[4-(1H-Indol-5-yl)-3,4-dimethyl-2,5-dioxo-imidazolidin-1-yl]-2-trifluoromethyl-benzonitrile
   Show/Hide
C21H15F3N4O2
 1
1
Activity = 70 nM
   TI
   LI
   LO
   TS
CP0956188
(+/-)-4-(4-Hydroxymethyl-3-methyl-2,5-dioxo-4-thiophen-3-yl-imidazolidin-1-yl)-2-trifluoromethylbenzonitrile
   Show/Hide
C17H12F3N3O3S
 1
1
Activity = 133 nM
   TI
   LI
   LO
   TS
CP0667052
rac-4-[2,5-Dioxo-4-(4-methoxyphenyl)-4-methylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
   Show/Hide
C19H14F3N3O3
 1
1
Activity = 150 nM
   TI
   LI
   LO
   TS
CP0883502
(+/-)-4-[4-(4-Cyanophenyl)-2,5-dioxo-4-hydroxymethyl-3-methylimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
   Show/Hide
C20H13F3N4O3
 1
1
Activity = 150 nM
   TI
   LI
   LO
   TS
CP0952907
(+/-)-4-(3-Acetyl-4-hydroxymethyl-2,5-dioxo-4-phenyl-imidazolidin-1-yl)-2-trifluoromethyl-benzonitrile
   Show/Hide
C20H14F3N3O4
 1
1
Activity = 150 nM
   TI
   LI
   LO
   TS
CP0957176
(+/-)-4-(4-Benzo[b]thiophen-2-yl-4-hydroxymethyl-3-methyl-2,5-dioxoimidazolidin-1-yl)-2-trifluoromethybenzonitrile
   Show/Hide
C17H12F3N3O3S
 1
1
Activity = 150 nM
   TI
   LI
   LO
   TS
CP0780211
rac-4-[3,4-dimethyl-2,5-dioxo-4-(4-hydroxyphenyl)imidazolidin-1-yl]-5-methyl-2-trifluoromethylbenzonitrile
   Show/Hide
C20H16F3N3O3
 1
1
Activity = 200 nM
   TI
   LI
   LO
   TS
CP0781306
(S)-4-[3,4-Dimethyl-2,5-dioxo-4-(4-hydroxyphenyl)-imidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
   Show/Hide
C19H14F3N3O3
 1
1
Activity = 200 nM
   TI
   LI
   LO
   TS
CP0667687
(R)-(+)-4-[2,5-Dioxo-4-(hydroxymethyl)-3-methyl-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
   Show/Hide
C19H14F3N3O3
 1
1
Activity = 1250 nM
   TI
   LI
   LO
   TS
CP0040191
2-Hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide
   Show/Hide
C11H11F3N2O4
 1
1
IC50 = 31 nM
   TI
   LI
   LO
   TS
CP0146696
Bicalutamide
   Show/Hide
C18H14F4N2O4S
 2
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
2
IC50 = 200 nM
   TI
   LI
   LO
   TS
CP0449746
3-(4-(3-((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl)propyl)phenoxy)propanoic acid
   Show/Hide
C32H44O5
 1
1
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0382180
8-((5S,7R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-7-yl)-N,N-dimethyloctanamide
   Show/Hide
C29H49NO3
 1
1
IC50 = 190 nM
   TI
   LI
   LO
   TS
CP0391116
8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N,N-dimethyloctanamide
   Show/Hide
C29H49NO3
 1
1
IC50 = 190 nM
   TI
   LI
   LO
   TS
CP0378458
7-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N,N-dimethylheptanamide
   Show/Hide
C28H47NO3
 1
1
IC50 = 200 nM
   TI
   LI
   LO
   TS
CP0344449
4-(3-Phenyl-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-trifluoromethylbenzonitrile
   Show/Hide
C19H14F3N3OS
 1
1
IC50 = 200 nM
   TI
   LI
   LO
   TS
CP0359162
3-[3-(3-Chloro-4-cyanophenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]propane-1-sulfonamide
   Show/Hide
C15H17ClN4O3S2
 1
1
IC50 = 200 nM
   TI
   LI
   LO
   TS
CP0427960
5-(4-(4-((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl)butyl)phenoxy)pentanoic acid
   Show/Hide
C35H50O5
 1
1
IC50 = 250 nM
   TI
   LI
   LO
   TS
CP0439471
5-(4-(3-((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl)propyl)phenoxy)pentanoic acid
   Show/Hide
C34H48O5
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0437253
N,N-diethyl-8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]octanamide
   Show/Hide
C31H53NO3
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0515900
8-(17b-hydroxy-5a-androstan-3-one-7a-yl)-1-(pyrrolidin-1-yl)octan-1-one
   Show/Hide
C31H51NO3
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0195890
3-[3-(4-Cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]benzenesulfonamide
   Show/Hide
C19H15F3N4O3S2
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0427065
5-(3-(4-((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl)butyl)phenoxy)pentanoic acid
   Show/Hide
C35H50O5
 1
1
IC50 = 330 nM
   TI
   LI
   LO
   TS
CP0437254
N-butyl-8-[(7R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-methyloctanamide
   Show/Hide
C32H55NO3
 1
1
IC50 = 340 nM
   TI
   LI
   LO
   TS
CP0437256
N-butyl-8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-methyloctanamide
   Show/Hide
C32H55NO3
 1
1
IC50 = 340 nM
   TI
   LI
   LO
   TS
CP0296445
3-[3-(3-Chloro-4-cyanophenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]benzenesulfonamide
   Show/Hide
C18H15ClN4O3S2
 1
1
IC50 = 400 nM
   TI
   LI
   LO
   TS
CP0427957
6-(4-(4-((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl)butyl)phenoxy)hexanoic acid
   Show/Hide
C36H52O5
 1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
CP0496892
8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-methyl-N-propan-2-yloctanamide
   Show/Hide
C31H53NO3
 1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
CP0515901
N-ethyl-8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-methyloctanamide
   Show/Hide
C30H51NO3
 1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
CP0522641
8-(17b-hydroxy-5a-androstan-3-one-7a-yl)octanamide
   Show/Hide
C27H45NO3
 1
1
IC50 = 450 nM
   TI
   LI
   LO
   TS
CP0515899
8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-methyloctanamide
   Show/Hide
C28H47NO3
 1
1
IC50 = 480 nM
   TI
   LI
   LO
   TS
CP0391115
8-(17b-hydroxy-5a-androstan-3-one-7a-yl)-1-(piperidin-1-yl)octan-1-one
   Show/Hide
C32H53NO3
 1
1
IC50 = 490 nM
   TI
   LI
   LO
   TS
CP0382179
6-(3-(4-((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl)butyl)phenoxy)hexanoic acid
   Show/Hide
C36H52O5
 1
1
IC50 = 530 nM
   TI
   LI
   LO
   TS
CP0505253
N,N-diethyl-7-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]heptanamide
   Show/Hide
C30H51NO3
 1
1
IC50 = 530 nM
   TI
   LI
   LO
   TS
CP0163140
6-[3-(3-Chloro-4-cyanophenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]pyridine-2-sulfonic acid amide
   Show/Hide
C17H14ClN5O3S2
 1
1
IC50 = 600 nM
   TI
   LI
   LO
   TS
CP0449747
4-(4-(3-((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl)propyl)phenoxy)butanoic acid
   Show/Hide
C33H46O5
 1
1
IC50 = 660 nM
   TI
   LI
   LO
   TS
CP0076394
6-[3-(4-Cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]pyridine-2-sulfonic acid amide
   Show/Hide
C18H14F3N5O3S2
 1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0427956
8-((5S,7R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-7-yl)octanoic acid
   Show/Hide
C27H44O4
 1
1
IC50 = 730 nM
   TI
   LI
   LO
   TS
CP0434490
8-(17b-hydroxy-5a-androstan-3-one-7a-yl)-1-(morpholin-4-yl)octan-1-one
   Show/Hide
C31H51NO4
 1
1
IC50 = 730 nM
   TI
   LI
   LO
   TS
CP0445429
4-(4-(4-((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl)butyl)phenoxy)butanoic acid
   Show/Hide
C34H48O5
 1
1
IC50 = 850 nM
   TI
   LI
   LO
   TS
CP0427063
4-(3-(4-((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl)butyl)phenoxy)butanoic acid
   Show/Hide
C34H48O5
 1
1
IC50 = 920 nM
   TI
   LI
   LO
   TS
CP0435260
10-((5S,7R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-7-yl)decanoic acid
   Show/Hide
C29H48O4
 1
1
IC50 = 920 nM
   TI
   LI
   LO
   TS
CP0434493
N-ethyl-8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]octanamide
   Show/Hide
C29H49NO3
 1
1
IC50 = 940 nM
   TI
   LI
   LO
   TS
CP0243191
5-[3-(4-Cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]pyridine-3-sulfonic acid amide
   Show/Hide
C18H14F3N5O3S2
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0344451
4-[3-(4-Cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]pyridine-2-sulfonic acid amide
   Show/Hide
C18H14F3N5O3S2
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0437258
8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-methyl-N-propyloctanamide
   Show/Hide
C31H53NO3
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0378454
N-butyl-11-[(7R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-methylundecanamide
   Show/Hide
C35H61NO3
 1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0522642
N-benzyl-8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-methyloctanamide
   Show/Hide
C35H53NO3
 1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0434494
N-butyl-10-[(7R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-methyldecanamide
   Show/Hide
C34H59NO3
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0501561
8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-propyloctanamide
   Show/Hide
C30H51NO3
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0449748
10-((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl)decanoic acid
   Show/Hide
C30H48O4
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0359227
5-[3-(3-Chloro-4-cyanophenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]pyridine-3-sulfonic acid amide
   Show/Hide
C17H14ClN5O3S2
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0515902
17b-hydroxy-7a-{9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl}-5a-androstan-3-one
   Show/Hide
C33H53F5O3S
 1
1
IC50 = 2900 nM
   TI
   LI
   LO
   TS
CP0378455
N-butyl-9-[(7R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-methylnonanamide
   Show/Hide
C33H57NO3
 1
1
IC50 = 3400 nM
   TI
   LI
   LO
   TS
CP0437259
N-butyl-12-[(7R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]-N-methyldodecanamide
   Show/Hide
C36H63NO3
 1
1
IC50 = 3500 nM
   TI
   LI
   LO
   TS
CP0427062
4-(3-(3-((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-yl)propyl)phenoxy)butanoic acid
   Show/Hide
C33H46O5
 1
1
IC50 = 5800 nM
   TI
   LI
   LO
   TS
CP0501559
N-butyl-8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]octanamide
   Show/Hide
C31H53NO3
 1
1
IC50 = 6300 nM
   TI
   LI
   LO
   TS
CP0437257
N-hexyl-8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]octanamide
   Show/Hide
C33H57NO3
 1
1
IC50 = 6600 nM
   TI
   LI
   LO
   TS
CP0500877
10-((5S,7R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-7-yl)-2-(4,4,5,5,5-pentafluoropentyl)decanoic acid
   Show/Hide
C34H53F5O4
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0372354
N,N-dihexyl-8-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-7-yl]octanamide
   Show/Hide
C39H69NO3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0378457
17b-hydroxy-7a-{13-(4,4,5,5,5-pentafluoropentylsulfinyl)tridecyl}-5a-androstan-3-one
   Show/Hide
C37H61F5O3S
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0434492
17beta-Hydroxy-7a-{5-(4,4,5,5,5-pentafluoropentylsulfinyl)17b-Hydroxy-7a-{5-(4,4,5,5,5-pentafluoropentylsulfinyl)pentyl}-5a-androstan-3-one
   Show/Hide
C29H45F5O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0437255
17b-hydroxy-7a-{11-(4,4,5,5,5-pentafluoropentylsulfinyl)undecyl}-5a-androstan-3-one
   Show/Hide
C35H57F5O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0444555
17b-hydroxy-7a-{7-(4,4,5,5,5-pentafluoropentylsulfinyl)heptyl}-5a-androstan-3-one
   Show/Hide
C31H49F5O3S
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS